Matches in Nanopublications for { ?s ?p "DDI between Caffeine and Conivaptan - Conivaptan may increase the serum concentration of CYP3A4 substrates such as caffeine. Upon completion/discontinuation of conivaptan, allow at least 7 days before initiating therapy with drugs that are CYP3A4 substrates. [drugbank_resource:DB00201_DB00872]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00201_DB00872 label "DDI between Caffeine and Conivaptan - Conivaptan may increase the serum concentration of CYP3A4 substrates such as caffeine. Upon completion/discontinuation of conivaptan, allow at least 7 days before initiating therapy with drugs that are CYP3A4 substrates. [drugbank_resource:DB00201_DB00872]" assertion.